The Furosemide Injection, cataloged under National Stock Number 6505-00-933-8704, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Abbott Laboratories Inc. Div Hospital Products Division. Government technical data includes 4 specifications, cited from the U.S. Government catalog. The record lists 1 manufacturer part number for this item, enabling identification through both NSN and commercial part number lookups. 3 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active.
| Parameter | Value |
|---|---|
| NSN | 6505-00-933-8704 |
| Primary Part Number | NDC00074-6102-02 |
| Item Name | Furosemide Injection |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Abbott Laboratories Inc. Div Hospital Products Division |
| Status | ACTIVE |
| Primary Container Content Quantity | 2.000 MILLILITERS |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Primary Container Type | VIAL |
| Active Medicament Medicinal Strength | 10.000 MILLIGRAMS FUROSEMIDE PER MILLILITER |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Part Number | Manufacturer |
|---|---|
| NDC00074-6102-02 PRIMARY | Abbott Laboratories Inc. Div Hospital Products Division (USA) |
| Reference | Meaning |
|---|---|
| LASIX INJECTION | 5/9 Secondary reference Hoechst-Roussel Pharmaceuticals Inc |
| NDC00039-0055-25 | 5/9 Secondary reference Hoechst-Roussel Pharmaceuticals Inc |
| NDC00641-0382-25 | 5/9 Secondary reference Elkins-Sinn Inc |
NSN 6505-00-933-8704 is a Furosemide Injection, manufactured by Abbott Laboratories Inc. Div Hospital Products Division, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-00-933-8704 has 1 manufacturer part number on file: NDC00074-6102-02 (Abbott Laboratories Inc. Div Hospital Products Division).
Key specifications for NDC00074-6102-02: Primary Container Content Quantity: 2.000 MILLILITERS; Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Primary Container Type: VIAL; Active Medicament Medicinal Strength: 10.000 MILLIGRAMS FUROSEMIDE PER MILLILITER. 4 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.